These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
529 related items for PubMed ID: 29289374
1. Safety of Flibanserin in Women Treated With Antidepressants: A Randomized, Placebo-Controlled Study. Clayton AH, Croft HA, Yuan J, Brown L, Kissling R. J Sex Med; 2018 Jan; 15(1):43-51. PubMed ID: 29289374 [Abstract] [Full Text] [Related]
5. Evaluation of Flibanserin Safety: Comparison with Other Serotonergic Medications. Kingsberg SA, McElroy SL, Clayton AH. Sex Med Rev; 2019 Jul; 7(3):380-392. PubMed ID: 30803922 [Abstract] [Full Text] [Related]
6. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials. Simon JA, Thorp J, Millheiser L. J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049 [Abstract] [Full Text] [Related]
11. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial. Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T, Sand M, Pyke R. J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348 [Abstract] [Full Text] [Related]
13. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial. Simon JA, Kingsberg SA, Shumel B, Hanes V, Garcia M, Sand M. Menopause; 2014 Jun; 21(6):633-40. PubMed ID: 24281236 [Abstract] [Full Text] [Related]
14. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study. Thorp J, Simon J, Dattani D, Taylor L, Kimura T, Garcia M, Lesko L, Pyke R, DAISY trial investigators. J Sex Med; 2012 Mar; 9(3):793-804. PubMed ID: 22239862 [Abstract] [Full Text] [Related]
15. Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis. Kamrul-Hasan ABM, Hannan MA, Alam MS, Aalpona FTZ, Nagendra L, Selim S, Dutta D. Medicine (Baltimore); 2024 Jun 21; 103(25):e38592. PubMed ID: 38905407 [Abstract] [Full Text] [Related]
16. Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis. Gao Z, Yang D, Yu L, Cui Y. J Sex Med; 2015 Nov 21; 12(11):2095-104. PubMed ID: 26745616 [Abstract] [Full Text] [Related]
18. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis. Jaspers L, Feys F, Bramer WM, Franco OH, Leusink P, Laan ET. JAMA Intern Med; 2016 Apr 21; 176(4):453-62. PubMed ID: 26927498 [Abstract] [Full Text] [Related]
19. Flibanserin for female sexual dysfunction. Reviriego C. Drugs Today (Barc); 2014 Aug 21; 50(8):549-56. PubMed ID: 25187905 [Abstract] [Full Text] [Related]
20. Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin. Simon JA, Clayton AH, Kim NN, Patel S. Sex Med; 2022 Feb 21; 10(1):100476. PubMed ID: 34999484 [Abstract] [Full Text] [Related] Page: [Next] [New Search]